课题基金 / 基金详情

Clinical and histopathological research on predictive evaluation of the effect of radiotherapy combined with or without chemotherapy for lung cancer

Clinical and histopathological research on predictive evaluation of the effect of radiotherapy combined with or without chemotherapy for lung cancer
肺癌放疗联合化疗疗效预测评价的临床及组织病理学研究
批准号:
15591300
负责人:
HAYAKAWA Kazushige
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HAYAKAWA Kazushige的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the present study, quantitative levels of telomerase activity and hTERT gene mRNA (hTERT) expression playing a key role in telomerase activation were analyzed in cancerous and non-cancerous lung tissues of 62 lung cancer patients by telomeric repeat amplification protocol and reverse transcription-PCR, respectively. The telomerase expression levels of each group of tissue samples were compared with clinicopathologic variables. Telomerase activity and hTERT were detected in cancerous tissues (75.8 and 75.8%, respectively), while these parameters were not observed in any non-cancerous tissues. In quantitative assessment of telomerase expression, both telomerase activity and hTERT were significantly correlated with lymph node metastasis (NO vs. N+, P<0.05). Telomerase activity also correlated with tumor cell differentiation and stage classification (P<0.05), but did not correlate with other clinicopathologic variables. The disease-free survival in patients with lung cancer demonstrated … More that patients with hTERT-positive tumor survived for a significantly shorter period than those with hTERT negative tumor (P=0.0334). Since hTERT levels are correlated with N factor which represents the true aggressiveness of patients' disease concerning the evaluation of clinical outcome, hTERT was found to be one of the important markers revealing biological malignant potentials for lung cancer. To reduce the normal tissue damag, we adopted three-dimensional (3D) conformal single high-dose boost radiosurgery (SRS) by using our spiro-analyzer respiratory gating system for peripheral T1 non-small cell lung cancer (NSCLC). Twenty-four palients were treated with a standard fractionation of 30 GY/10 fractions or 40 Gy/20 fractions and a single high-dose boost of 20 Gy using 3D non-coplanar SRS. Twenty tumors (83%) showed a local responce. No radiation pneumonitis greater than National Cancer Institute-Common Toxicity Criteria Grade 1 was noted except one patient had grade 2 pneumonitis. 3D conformal single high-dose boost SRS using our respiratory gating system was useful for the treatment of peripheral TI NSCLC. Less
期刊论文(53)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2004
期刊: Anticancer Res. 24・3b
影响因子: --
作者: [Niibe Y, Karasawa K, Hayakawa K]
通讯作者: Hayakawa K
DOI: --
发表时间: 2003
期刊: JMAJ 46・12
影响因子: --
作者: [Kitamoto Y, Nakayama Y, Hayakawa K, et al., Hayakawa K]
通讯作者: Hayakawa K
Kitamoto Y, Nakayama Y, Hayakawa_K, et al.: "Retrospective study of treatment results for limite-stage small-cell lung cancer in National Nishigunma Hospital."J Jpn Soc Ther Radiol Oncol. 15・2. 145-150 (2003)
Kitamoto Y、Nakayama Y、Hayakawa_K 等:“国立西群马医院有限期小细胞肺癌治疗结果的回顾性研究”Jpn Soc Ther Radiol Oncol 15・2(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma : clinical outcomes in 245 subjects in a Japanese multiinstitutional study
立体定向大分割高剂量照射治疗 I 期非小细胞肺癌:日本多机构研究中 245 名受试者的临床结果
DOI: --
发表时间: 2004
期刊: Cancer 101・7
影响因子: --
作者: [Onishi H, Hayakawa K, et al.]
通讯作者: et al.
24
    Clinico-pathological research for predictive factors of the treatment effects in radiation therapy combined with or without chemotherapy for lung cancer
    • 批准号:
      21591617
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      HAYAKAWA Kazushige
    • 依托单位:
    Clinical and molecular histo-pathological research on predictive evaluation of the effect of radiotherapy combined with or without molecular targeting agents for lung cancer
    • 批准号:
      18591391
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.49万
    • 财政年份:
      2006
    • 负责人:
      HAYAKAWA Kazushige
    • 依托单位:
    Clinical and histopathological research on radiation therapy in the multidisciplinary treatment of non-small cell lung cancer
    • 批准号:
      13670962
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      HAYAKAWA Kazushige
    • 依托单位:
    Clinical and histopathological research on radiation therapy for early stage non-small cell lung cancer
    • 批准号:
      10670826
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.32万
    • 财政年份:
      1998
    • 负责人:
      HAYAKAWA Kazushige
    • 依托单位:
    海外基金